FDA Panel Supports HeartWare VAD, Despite Trial Shortcomings
This article was originally published in The Gray Sheet
Executive Summary
Benefits of HeartWare system, as well as the prospect of adding a competitive device to a market currently dominated by a single product, overshadow uncertainties from missing data, panelists vote.